Ir para o conteúdo principal

United States Últimas notícias

Todas as matérias desta categoria, das mais recentes às mais antigas.

Grafa
Oil and Gas

Baytex sets 2026 budget along with production growth

Baytex Energy Corp. (NYSE:BTE) has announced its 2026 budget, outlining plans for production growth, strategic shareholder returns, and significant leadership changes. The company targets a 3%–5% production growth in Canada for the upcoming year, with an expected average production of 67,000–69,000 barrels of oil equivalent per day (boe/d), based on a US$60 WTI price.

Leia mais: Baytex sets 2026 budget along with production growth
Grafa
Technology

GEO Group subsidiary wins $121M ICE contract for fugitive recovery services

The GEO Group (NYSE:GEO), a leading provider of government-contracted services, announced on Monday that its wholly-owned subsidiary, BI Incorporated, has been awarded a significant new contract by U.S. Immigration and Customs Enforcement (ICE).

Leia mais: GEO Group subsidiary wins $121M ICE contract for fugitive recovery services
Grafa
Health

Greenwich LifeSciences maintains momentum in Phase III breast cancer trial

Greenwich LifeSciences (NASDAQ:GLSI) provided a comprehensive year-end update on Monday for its pivotal Phase III clinical trial, FLAMINGO-01.

The trial is evaluating GLSI-100, a Fast Track-designated immunotherapy designed to prevent breast cancer recurrence in HER2-positive patients.

Leia mais: Greenwich LifeSciences maintains momentum in Phase III breast cancer trial
Grafa
Industrials

Honeywell adjusts 2025 outlook following Advanced Materials spin and litigation charges

Honeywell International (NASDAQ:HON) issued a comprehensive update to its financial projections on Monday, recalibrating its 2025 guidance to account for the strategic spin-off of its Advanced Materials business.

Leia mais: Honeywell adjusts 2025 outlook following Advanced Materials spin and litigation charges
Grafa
Health

KalVista gains Japan approval for world’s first oral on-demand HAE therapy

KalVista Pharmaceuticals (NASDAQ:KALV) has received marketing and manufacturing approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) for EKTERLY (sebetralstat), establishing it as the first and only oral on-demand treatment for hereditary angioedema (HAE) in the country.

Leia mais: KalVista gains Japan approval for world’s first oral on-demand HAE therapy
Grafa
Manufacturing

Ennis reports higher Q3 earnings as margin expansion offsets revenue volatility

Ennis (NYSE:EBF), a major manufacturer of printed business products, reported an increase in third-quarter profitability on Monday, as significant margin expansion helped the company overcome a softer nine-month revenue trend.

Leia mais: Ennis reports higher Q3 earnings as margin expansion offsets revenue volatility
Grafa
Health

ENHERTU wins 10th FDA breakthrough status to target early breast cancer

AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo have secured their tenth Breakthrough Therapy Designation (BTD) from the U.S. Food and Drug Administration for ENHERTU, marking a pivotal step in moving the blockbuster treatment into earlier, potentially curative stages of breast cancer.

Leia mais: ENHERTU wins 10th FDA breakthrough status to target early breast cancer